Imbrave 150 Trial Atezolizumab Bevacizumab In Liver Cancer An Immunotherapy Trial

Summary

First-line treatment options for advanced HCC including sorafenib, lenvatinib, and Peter R. Galle, MD, PhD, Johannes Gutenberg University, Mainz, Germany, shares updated efficacy data from the Phase III ... Dr. Finn, Professor, Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, Director, Signal ... Prof Pierce Chow speaks to ecancer as part of AACR 2023 about the phase III IMbrave050 Pierce Chow, MBBS, MMed (Surg), FRCS (Edin), FAMS (Gen Surg), PhD, National Michael Pishvaian, MD, PhD, of Georgetown University, Washington, WA, describes the process and outcomes of the Phase 1b ... Cancer Research And Statistic Foundation organized a webinar " The role of sorafenib in the first-line treatment of HCC as seen in the Prof Richard Finn speaks to ecancer in an online interview for the virtual AACR 2021 meeting about the updated safety and ...